Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.54 |
| ▸ | CASP2 | P42575 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30274291 | 0.96 | FAAH (0.50) | FAAHCASP2DNM1NAAAPSMD14 | |
| SCHEMBL10329413 | 0.95 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 | |
| SCHEMBL13199359 | 0.95 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 | |
| SCHEMBL17707881 | 0.94 | FAAH (0.51) | FAAHCASP2DNM1NAAAPSMD14 | |
| SCHEMBL29817227 | 0.93 | FAAH (0.50) | FAAHCASP2DNM1NAAAPSMD14 | |
| SCHEMBL20959426 | 0.93 | FAAH (0.50) | FAAHCASP2DNM1NAAAPSMD14 | |
| Hydrochloric Acid SCHEMBL29528833 | 0.92 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 | |
| Hydrochloric Acid SCHEMBL1428153 | 0.92 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 | |
| Hydrochloric Acid SCHEMBL15534461 | 0.92 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 | |
| Hydrochloric Acid SCHEMBL15534882 | 0.92 | FAAH (0.49) | FAAHCASP2DNM1NAAAPSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2325278-B1 | Polycationic viscoelastic compositions | STEPAN CO (US) | 2015-09-09 | — | — | EP | disclosed |
| US-8222455-B2 | Polycationic viscoelastic compositions | STEPAN COMPANY (US) | 2012-07-17 | — | — | US | disclosed |
| US-20110190530-A1 | Polycationic Viscoelastic Compositions | KNOX PAUL | 2011-08-04 | — | — | US | disclosed |
| US-7947633-B2 | Polycationic viscoelastic compositions | STEPAN COMPANY (US) | 2011-05-24 | — | — | US | disclosed |
| US-7884057-B2 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY (US) | 2011-02-08 | — | — | US | disclosed |
| US-7879769-B2 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY (US) | 2011-02-01 | — | — | US | disclosed |
| US-20100311622-A1 | Polycationic Viscoelastic Compositions | KNOX PAUL | 2010-12-09 | — | — | US | disclosed |
| US-7772165-B2 | Polycationic viscoelastic compositions | STEPHAN COMPANY (US) | 2010-08-10 | — | — | US | disclosed |
| US-20080255009-A1 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY | 2008-10-16 | — | — | US | disclosed |
| US-20080248976-A1 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY | 2008-10-09 | — | — | US | disclosed |
| US-20080248977-A1 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY | 2008-10-09 | — | — | US | disclosed |
| WO-2007056392-A9 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN CO (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007056284-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056393-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056392-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190530-A1 | Polycationic Viscoelastic Compositions | AQP1, PBRM1, PARG | FAAH 3634/4885CASP2 3230/4885DNM1 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.